Local school districts in Wisconsin face funding challenges as state budget relies on local taxpayers for increased spending.

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alc ...